Neuronetics, Inc. Files 8-K
Ticker: STIM · Form: 8-K · Filed: Oct 4, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Oct 4, 2024 |
| Risk Level | low |
| Pages | 9 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Neuronetics filed an 8-K, standard reporting, no new material news.
AI Summary
Neuronetics, Inc. filed an 8-K on October 4, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Neuronetics, Inc. is complying with SEC reporting requirements, but it does not disclose new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, not indicating any specific new risks or material events.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- October 4, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3222 Phoenixville Pike, Malvern, PA 19355 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Neuronetics, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and Financial Statements and Exhibits.
On what date was this 8-K filing reported as of?
The 8-K filing was reported as of October 4, 2024.
In which U.S. state is Neuronetics, Inc. incorporated?
Neuronetics, Inc. is incorporated in Delaware.
What is the address of Neuronetics, Inc.'s principal executive offices?
The address of Neuronetics, Inc.'s principal executive offices is 3222 Phoenixville Pike, Malvern, PA 19355.
Does this 8-K filing disclose any specific new financial results or material events?
This 8-K filing does not appear to disclose specific new financial results or material events beyond the standard reporting categories of Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Stats: 2,611 words · 10 min read · ~9 pages · Grade level 17.1 · Accepted 2024-10-04 08:54:00
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
Filing Documents
- d828796d8k.htm (8-K) — 55KB
- d828796dex991.htm (EX-99.1) — 21KB
- g828796g1004085941002.jpg (GRAPHIC) — 4KB
- g828796g1004085941278.jpg (GRAPHIC) — 4KB
- 0001193125-24-232682.txt ( ) — 217KB
- stim-20241004.xsd (EX-101.SCH) — 3KB
- stim-20241004_lab.xml (EX-101.LAB) — 17KB
- stim-20241004_pre.xml (EX-101.PRE) — 11KB
- d828796d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 4, 2024 NEURONETICS, INC. By: /s/ W. Andrew Macan W. Andrew Macan EVP, GC & Chief Compliance Officer 3